Catalyst Wire Dossier Catalyst Wire Dossier

RIFABUTIN

Rifabutin · Mylan Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

36 regulatory and trial events tracked for RIFABUTIN, covering 2008-05-14 to 2026-08-21. Get the full timeline:

Most recent: FDA Approved: RIFABUTIN — Original Application (ZYDUS LIFESCIENCES)

See pricing